The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda.
about
Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control.Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcerAnalysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected miceImproved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boostingBCG-mediated protection against Mycobacterium ulcerans infection in the mouse.Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.Buruli ulcer.Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo.Epidemiology of infection by nontuberculous mycobacteriaDifferential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease.How far have we reached in tuberculosis vaccine development?Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.Risk factors for Buruli ulcer, Benin.Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulceransOverexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine EfficacyMycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer diseaseAnalysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection.Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection.Revisiting Buruli ulcer.A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.Epidemiology of Buruli ulcer in Amansie West district, Ghana.Mycobacterium ulcerans infection in Ashanti region, Ghana.DNA vaccines against mycobacterial diseasesBuruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulceransLow incidence of recurrent Buruli ulcers in treated Australian patients living in an endemic regionIFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with infection
P2860
Q21144731-57220CEC-2A9E-414A-B54D-1D10DF4A5D95Q24548647-AC07736E-AF4C-43CA-BD1B-BC4F8DE10F9CQ28538249-AF64E0ED-4DDD-4A5E-B7E3-8F18E925456CQ33324374-6BA99A4D-D555-4BF0-9F5A-B511ED28E276Q33851427-237FBB07-9C93-44C1-9482-A9CDC0B00E3AQ34033119-86816E8B-8188-4343-BC24-117DC94E37D9Q34174558-96BCA6A7-B28A-4B7E-9A01-095E95DCA2A9Q34193844-7A013B4A-AC81-4D98-9563-A2F85D995D89Q34229628-D1A7647E-E2D3-4CE6-911D-A728BB1ABBECQ34484489-A298909D-8B31-464D-BB04-1ADE50231F46Q34875651-46D08B29-DCF7-4A89-B429-7116E0FC9F2BQ35370226-75B8B991-351A-431C-A58C-8AA9149BBACDQ35549819-69BD2002-8F56-4075-B37F-D11A9A63F8E4Q35592360-58C7EBFF-A68E-4AE2-8F6D-96DC832DF16AQ35625819-1A6195A1-97F3-4B8F-AF0E-DEC392022969Q35746584-75F407B4-7382-4980-BF27-682B77053E6AQ35782951-213C2CAD-6D9A-4FA0-B6D7-9558068C2E83Q35805701-2CF5484C-3158-4B4D-B7AC-B3B20006ADBEQ35915755-94D5CC34-9432-45CA-AE85-B0429B3F8DF4Q35919532-14441A11-142E-4450-B0F9-E245526DE2ECQ36063218-0850A7BB-7341-4A58-8FF3-F8079A335FCEQ36219941-271B7F95-DDD0-4A06-AE85-34186DE0C069Q36227714-F5208FC5-374D-4D91-AF0F-6DBD8BF5EE0DQ36291527-43B05387-9B33-4E21-B1ED-498BE419B8FFQ36618316-B3FBF9E4-D6ED-427A-92DC-862EA89A5E12Q37349850-A6747DC8-F75A-4073-A330-4EA5EF90ADAFQ38001023-D507B344-8741-4478-B388-ECDCFF7B469FQ38579126-3B41C0D6-2FEF-4FEC-A010-79196359A179Q42799618-4C484143-77E3-44C2-B4A1-03BCD0ED02B0Q46241939-795FAB9C-0687-40B2-A74F-B76CE8907EB5Q46854734-B740D6D4-AAF7-4A96-B51D-F9747A6A0366Q46876737-2FFC0CEA-E1F7-4E4E-8239-595ADB06067BQ57203115-C948DCD9-D7B4-45D2-AB10-04E62C688E7FQ57203196-A56C30D6-59C8-4BBD-A098-C854017E10ACQ58785261-48DB3797-5E1D-4538-BB69-8CA042F1DFF2Q58880192-F494BE49-6C12-4055-B728-0919C6AB6F13
P2860
The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
The protective effect of BCG a ...... in an endemic area of Uganda.
@en
type
label
The protective effect of BCG a ...... in an endemic area of Uganda.
@en
prefLabel
The protective effect of BCG a ...... in an endemic area of Uganda.
@en
P2093
P2860
P1476
The protective effect of BCG a ...... in an endemic area of Uganda.
@en
P2093
P2860
P304
P356
10.1016/0035-9203(76)90128-0
P577
1976-01-01T00:00:00Z